RHI AG / RHI places EUR 170 million Schuldscheindarlehen

24.09.2014, 1283 Zeichen

Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement.

Financing, Stock Offerings (IPO)
RHI, a world market leader for refractory products, successfully closed the order book for a EUR 170 million Schuldscheindarlehen on September 24, 2014.
Due to strong demand, the originally planned volume of EUR 75 million was increased to EUR 170 million. The Schuldscheindarlehen with terms of five, seven and ten years was primarily placed with Austrian and German investors. Preference was given to the longer terms in the allocation.
RHI will use the proceeds from the transaction to refinance upcoming repayments and to secure liquidity in the long term.
Landesbank Hessen-Thüringen, Frankfurt, and UniCredit Bank Austria AG, Vienna, supported the transaction as arrangers.

end of announcement euro adhoc
company: RHI AG Wienerbergstrasse 9 A-1100 Wien phone: +43 (0)50213-6676 FAX: +43 (0)50213-6130 mail: rhi@rhi-ag.com WWW: http://www.rhi-ag.com sector: Refractories ISIN: AT0000676903 indexes: ATX Prime, ATX

stockmarkets: official market: Wien language: English
Digital press kit: http://www.ots.at/pressemappe/1644/aom

Christian Drastil: Wiener Börse Plausch

Wiener Börse Party #1198: ATX schwächer, guter Tag für Semperit, 2. Versuch vom Sommerloch und eine klare Präferenz bei Addiko Bank

RHI Letzter SK:  0.00 ( 0.00%)

Bildnachweis

1. RHI , (© finanzmarktfoto.at/Martina Draper)   >> Öffnen auf photaq.com

Aktien auf dem Radar:Porr, Kapsch TrafficCom, Flughafen Wien, EuroTeleSites AG, RHI Magnesita, Austriacard Holdings AG, OMV, Telekom Austria, voestalpine, Verbund, SBO, Lenzing, Strabag, FACC, Bawag, Andritz, Addiko Bank, Frequentis, RBI, Semperit, BKS Bank Stamm, Marinomed Biotech, Amag, CPI Europe AG, Österreichische Post, UBM, IBM, Goldman Sachs, Commerzbank, Fresenius Medical Care, Mercedes-Benz Group.

---

Mehr aktuelle OTS-Meldungen HIER